Bioartificial heart: A human-sized porcine model - The way ahead

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Weymann, Alexander ^a   Patil, Nikhil Prakash ^b   Sabashnikov, Anton ^b   Jungebluth, Philipp ^c   Korkmaz, Sevil ^a   Li, Shiliang ^a   Veres, Gabor ^a   Soos, Pal ^d   Ishtok, Roland ^d   Chaimow, Nicole ^a   Pätzold, Ines ^a   Czerny, Natalie ^a   Schies, Carsten ^a   Schmack, Bastian ^a   Popov, Aron Frederik ^b   Simon, André Rüdiger ^b   Karck, Matthias ^a   Szabo, Gabor ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HAREFIELD HOSPITAL   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ELASTIN; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; BIOARTIFICIAL HEART; BIOARTIFICIAL ORGAN; BIOMECHANICS; COLLAGEN FIBER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DECELLULARIZATION; DNA DETERMINATION; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; HEART CELL CULTURE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HUMAN; HUMAN CELL; MOUSE; MYOELECTRICITY; NONHUMAN; PORCINE MODEL; PROCEDURES CONCERNING CELLS; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; ANIMAL MODEL; ARTIFICIAL HEART; CYTOLOGY; FEMALE; HEART MUSCLE CELL; PIG; PROCEDURES; TISSUE REGENERATION; UMBILICAL VEIN ENDOTHELIAL CELL;

MURINAE; SUS;

ANIMALS; FEMALE; GUIDED TISSUE REGENERATION; HEART, ARTIFICIAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MODELS, ANIMAL; MYOCYTES, CARDIAC; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84909953317     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111591     Document Type: Article

References (22)

1. Kobashigawa JA, Patel JK (2006) Immunosuppression for heart transplantation: Where are we now? Nat Clin Pract Cardiovasc Med 3: 203-212.
2. Tonsho M, Michel S, Ahmed Z, Alessandrini A, Madsen JC (2014) Heart transplantation: Challenges facing the field. Cold Spring Harb Perspect Med 4.
3. Badylak SF, Freytes DO, Gilbert TW (2009) Extracellular matrix as a biological scaffold material: Structure and function. Acta biomaterialia 5: 1-13.
4. Weymann A, Dohmen PM, Grubitzsch H, Dushe S, Holinski S, et al. (2010) Clinical experience with expanded use of the Ross procedure: A paradigm shift? J Heart Valve Dis 19: 279-285.
5. Weymann A, Radovits T, Schmack B, Li S, Korkmaz S, et al. (2014) In vitro generation of atrioventricular heart valve neoscaffolds. Artif Organs 38: 118-128.
6. Weymann A, Schmack B, Okada T, Soos P, Istok R, et al. (2013) Reendothelialization of human heart valve neoscaffolds using umbilical cordderived endothelial cells. Circ J 77: 207-216.
7. Robertson MJ, Dries-Devlin JL, Kren SM, Burchfield JS, Taylor DA (2014) Optimizing recellularization of whole decellularized heart extracellular matrix. PLoS One 9: 90406.
8. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, et al. (2008) Perfusiondecellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221.
9. Hulsmann J, Aubin H, Kranz A, Godehardt E, Munakata H, et al. (2013) A novel customizable modular bioreactor system for whole-heart cultivation under controlled 3D biomechanical stimulation. J Artif Organs 16: 294-304.
10. Wainwright JM, Czajka CA, Patel UB, Freytes DO, Tobita K, et al. (2010) Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue engineering Part C Methods 16: 525-532.
11. Weymann A, Loganathan S, Takahashi H, Schies C, Claus B, et al. (2011) Development and evaluation of a perfusion decellularization porcine heart model-generation of 3-dimensional myocardial neoscaffolds. Circ J 75: 852-860.
12. Weymann A, Sabashnikov A, Patil NP, Konertz W, Modersohn D, et al. (2014) Eprosartan improves cardiac function in swine working heart model of ischemiareperfusion injury. Med Sci Monit Basic Res 20: 55-62.
13. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, et al. (2002) Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106: 163-168.
14. Gopalan SM, Flaim C, Bhatia SN, Hoshijima M, Knoell R, et al. (2003) Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers. Biotechnol Bioeng 81: 578-587.
15. Eschenhagen T, Zimmermann WH (2005) Engineering myocardial tissue. Circ Res 97: 1220-1231.
16. Robinson KA, Li J, Mathison M, Redkar A, Cui J, et al. (2005) Extracellular matrix scaffold for cardiac repair. Circulation 112: 135-143.
17. Zimmermann WH, Schneiderbanger K, Schubert P, Didie M,Münzel F, et al. (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90: 223-230.
18. Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, et al. (1999) Survival and function of bioengineered cardiac grafts. Circulation 100: 163-169.
19. Sekine H, Shimizu T, Kosaka S, Kobayashi E, Okano T (2006) Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. J Heart Lung Transplant 25: 324-332.
20. Radisic M, Deen W, Langer R, Vunjak-Novakovic G (2005) Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288: 1278-1289.
21. Hara H, Long C, Lin YJ, Tai HC, Ezzelarab M, et al. (2008) In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int 21: 1163-1174.
22. Barallobre-Barreiro J, Didangelos A, Schoendube FA, Drozdov I, Yin X, et al. (2012) Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 125: 789-802.